2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
about
Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme dataA comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoningProvocative chelation with DMSA and EDTA: evidence for differential access to lead storage sitesReductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposureSafety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part I: History, neuropsychological findings and chelator effects.Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patientsThe scientific basis for chelation: animal studies and lead chelationMonensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in ratsMetabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.Lead toxicosis in cats-a review.Lead poisoning: case studies.Meso-2,3-dimercaptosuccinic acid in the diagnosis and treatment of lead poisoning.An oral treatment for lead toxicity.Nano drug delivery systems: a new paradigm for treating metal toxicity.Chelation therapy for childhood lead poisoning. The changing scene in the 1990s.Co-administration of monoisoamyl dimercaptosuccinic acid and Moringa oleifera seed powder protects arsenic-induced oxidative stress and metal distribution in mice.Chelation therapy in workers with lead exposure.Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA).delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins.Comparative in vivo lead mobilization of meso- and rac-2,3-dimercaptosuccinic acids in albino Wistar rats.Chronic lead poisoning treated with dimercaptosuccinic acid.Oral meso-2,3-dimercaptosuccinic acid in pregnant Sprague-Dawley rats: teratogenicity and alterations in mineral metabolism. I. Teratological evaluation.The Effect of 2, 3 Dimercaptosuccinic Acid in the Treatment of Lead Poisoning in Adults
P2860
Q21562279-FF7BD374-0543-4863-BEAC-428F7C54FCCAQ22305684-199D1490-E266-4BD9-88CA-F10125E9853CQ22306524-BCF4D01A-14A6-4660-8DB8-31D6F3169CBAQ24811181-F521EBE6-676F-452F-BFD0-41DA8955D3FDQ33912579-1158AD77-3FBC-44D2-B6A6-28D761809C09Q34243230-E55BFEC9-53BA-4C2D-98B8-6EECE45BC3DEQ34272841-7C36D872-E84B-4482-B520-6AAF3E10DEC1Q34376787-DEF283A9-BE36-43E0-A5D5-549818394A8AQ34547063-6D25B7D0-263B-4E21-AA15-F9DA64A7047AQ34864533-9D829F22-7D34-4C9F-89B5-D16DEDE423C0Q34996161-8DA0B9AA-3AAB-4E60-A153-35F125350ACFQ35033468-52965DF4-2D3B-433C-92C2-E0C3D64E6DAFQ35209120-44BD2602-B8F4-4E7E-9D9A-E62DE19C5969Q35803828-A5B0DA8B-FB9E-4249-809E-9D40FE8BC5D2Q38596163-5CC7F5D0-F81C-481D-A871-9E8C057F8E2FQ38650306-20533A65-E365-4B42-A7ED-C036560BC8C1Q38794257-4CA509E9-9300-4AFC-AFC1-08DDB1D6EF00Q40855805-C73E788F-7955-4F4B-B61A-50AD496BE928Q41993941-EFC4D911-B1AB-484E-8191-F02AC769662CQ42043349-732F8747-6CAC-4A5A-B972-B4B2BC07A53EQ42592488-35CB88D3-D422-43A3-9C5D-FD23D34CD3EDQ42789190-576F296C-46B9-4C82-AB81-03FE91B5F518Q44266342-49D93455-4311-466B-B81A-38EAF4C59FBAQ48432398-1D0643EC-6759-4639-B715-A7DC4A59C45BQ48739133-F82FDB62-AA78-4F8D-B6EC-ADB956AAF192Q52051221-B45C3B77-570C-4504-AE07-F81A1F0307AAQ52240968-37D5DF49-AB31-45BF-9C6A-5C4C714240F5Q58284778-E359CEAC-BCB3-4F1F-9AE7-903514E4EEFC
P2860
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
description
1985 nî lūn-bûn
@nan
1985 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@ast
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@en
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@nl
type
label
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@ast
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@en
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@nl
prefLabel
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@ast
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@en
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@nl
P2093
P356
P1476
2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
@en
P2093
Graziano JH
LoIacono N
Silverberg SJ
P304
P356
10.1038/CLPT.1985.67
P407
P577
1985-04-01T00:00:00Z